Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells.

Sliker BH, Goetz BT, Peters HL, Poelaert BJ, Borgstahl GEO, Solheim JC.

Cancer Biol Ther. 2019;20(6):931-940. doi: 10.1080/15384047.2019.1580414. Epub 2019 Feb 27.

PMID:
30810435
2.

The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.

Mao W, Peters HL, Sutton MN, Orozco AF, Pang L, Yang H, Lu Z, Bast RC Jr.

Cancer. 2019 Apr 15;125(8):1267-1280. doi: 10.1002/cncr.31935. Epub 2019 Jan 8.

PMID:
30620384
3.

Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma.

Alatrash G, Perakis AA, Kerros C, Peters HL, Sukhumalchandra P, Zhang M, Jakher H, Zope M, Patenia R, Sergeeva A, Yi S, Young KH, Philips AV, Cernosek AM, Garber HR, Qiao N, Weng J, St John LS, Lu S, Clise-Dwyer K, Mittendorf EA, Ma Q, Molldrem JJ.

Clin Cancer Res. 2018 Jul 15;24(14):3386-3396. doi: 10.1158/1078-0432.CCR-17-2626. Epub 2018 Apr 16.

4.

Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering.

Dingle AM, Yap KK, Gerrand YW, Taylor CJ, Keramidaris E, Lokmic Z, Kong AM, Peters HL, Morrison WA, Mitchell GM.

Angiogenesis. 2018 Aug;21(3):581-597. doi: 10.1007/s10456-018-9610-0. Epub 2018 Mar 26.

PMID:
29582235
5.

Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells.

Kerros C, Tripathi SC, Zha D, Mehrens JM, Sergeeva A, Philips AV, Qiao N, Peters HL, Katayama H, Sukhumalchandra P, Ruisaard KE, Perakis AA, St John LS, Lu S, Mittendorf EA, Clise-Dwyer K, Herrmann AC, Alatrash G, Toniatti C, Hanash SM, Ma Q, Molldrem JJ.

J Biol Chem. 2017 Jun 16;292(24):10295-10305. doi: 10.1074/jbc.M116.773051. Epub 2017 May 3.

6.

Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells.

Peters HL, Tripathi SC, Kerros C, Katayama H, Garber HR, St John LS, Federico L, Meraz IM, Roth JA, Sepesi B, Majidi M, Ruisaard K, Clise-Dwyer K, Roszik J, Gibbons DL, Heymach JV, Swisher SG, Bernatchez C, Alatrash G, Hanash S, Molldrem JJ.

Cancer Immunol Res. 2017 Apr;5(4):319-329. doi: 10.1158/2326-6066.CIR-16-0141. Epub 2017 Mar 2.

7.

Novel Mouse Models of Methylmalonic Aciduria Recapitulate Phenotypic Traits with a Genetic Dosage Effect.

Forny P, Schumann A, Mustedanagic M, Mathis D, Wulf MA, Nägele N, Langhans CD, Zhakupova A, Heeren J, Scheja L, Fingerhut R, Peters HL, Hornemann T, Thony B, Kölker S, Burda P, Froese DS, Devuyst O, Baumgartner MR.

J Biol Chem. 2016 Sep 23;291(39):20563-73. doi: 10.1074/jbc.M116.747717. Epub 2016 Aug 12.

8.

Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells.

Chawla A, Alatrash G, Philips AV, Qiao N, Sukhumalchandra P, Kerros C, Diaconu I, Gall V, Neal S, Peters HL, Clise-Dwyer K, Molldrem JJ, Mittendorf EA.

Cancer Immunol Immunother. 2016 Jun;65(6):741-51. doi: 10.1007/s00262-016-1841-6. Epub 2016 Apr 29.

9.

ALG1-CDG: Clinical and Molecular Characterization of 39 Unreported Patients.

Ng BG, Shiryaev SA, Rymen D, Eklund EA, Raymond K, Kircher M, Abdenur JE, Alehan F, Midro AT, Bamshad MJ, Barone R, Berry GT, Brumbaugh JE, Buckingham KJ, Clarkson K, Cole FS, O'Connor S, Cooper GM, Van Coster R, Demmer LA, Diogo L, Fay AJ, Ficicioglu C, Fiumara A, Gahl WA, Ganetzky R, Goel H, Harshman LA, He M, Jaeken J, James PM, Katz D, Keldermans L, Kibaek M, Kornberg AJ, Lachlan K, Lam C, Yaplito-Lee J, Nickerson DA, Peters HL, Race V, Régal L, Rush JS, Rutledge SL, Shendure J, Souche E, Sparks SE, Trapane P, Sanchez-Valle A, Vilain E, Vøllo A, Waechter CJ, Wang RY, Wolfe LA, Wong DA, Wood T, Yang AC; University of Washington Center for Mendelian Genomics, Matthijs G, Freeze HH.

Hum Mutat. 2016 Jul;37(7):653-60. doi: 10.1002/humu.22983. Epub 2016 Mar 21.

10.

Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome.

Tripathi SC, Peters HL, Taguchi A, Katayama H, Wang H, Momin A, Jolly MK, Celiktas M, Rodriguez-Canales J, Liu H, Behrens C, Wistuba II, Ben-Jacob E, Levine H, Molldrem JJ, Hanash SM, Ostrin EJ.

Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1555-64. doi: 10.1073/pnas.1521812113. Epub 2016 Feb 29.

11.

Amyloid precursor protein and amyloid precursor-like protein 2 in cancer.

Pandey P, Sliker B, Peters HL, Tuli A, Herskovitz J, Smits K, Purohit A, Singh RK, Dong J, Batra SK, Coulter DW, Solheim JC.

Oncotarget. 2016 Apr 12;7(15):19430-44. doi: 10.18632/oncotarget.7103. Review.

12.

Flexibility as a Strategy in Nucleoside Antiviral Drug Design.

Peters HL, Ku TC, Seley-Radtke KL.

Curr Med Chem. 2015;22(34):3910-21. Review.

PMID:
26282942
13.

Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity.

Peters HL, Jochmans D, de Wilde AH, Posthuma CC, Snijder EJ, Neyts J, Seley-Radtke KL.

Bioorg Med Chem Lett. 2015 Aug 1;25(15):2923-6. doi: 10.1016/j.bmcl.2015.05.039. Epub 2015 May 23.

14.

Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis.

Pandey P, Rachagani S, Das S, Seshacharyulu P, Sheinin Y, Naslavsky N, Pan Z, Smith BL, Peters HL, Radhakrishnan P, McKenna NR, Giridharan SS, Haridas D, Kaur S, Hollingsworth MA, MacDonald RG, Meza JL, Caplan S, Batra SK, Solheim JC.

Oncotarget. 2015 Feb 10;6(4):2064-75.

15.

Correction of methylmalonic aciduria in vivo using a codon-optimized lentiviral vector.

Wong ES, McIntyre C, Peters HL, Ranieri E, Anson DS, Fletcher JM.

Hum Gene Ther. 2014 Jun;25(6):529-38. doi: 10.1089/hum.2013.111. Epub 2014 Apr 2.

16.

A founder mutation in PET100 causes isolated complex IV deficiency in Lebanese individuals with Leigh syndrome.

Lim SC, Smith KR, Stroud DA, Compton AG, Tucker EJ, Dasvarma A, Gandolfo LC, Marum JE, McKenzie M, Peters HL, Mowat D, Procopis PG, Wilcken B, Christodoulou J, Brown GK, Ryan MT, Bahlo M, Thorburn DR.

Am J Hum Genet. 2014 Feb 6;94(2):209-22. doi: 10.1016/j.ajhg.2013.12.015. Epub 2014 Jan 23.

17.

APLP2 regulates the expression of MHC class I molecules on irradiated Ewing's sarcoma cells.

Peters HL, Yan Y, Solheim JC.

Oncoimmunology. 2013 Oct 1;2(10):e26293. Epub 2013 Oct 8.

18.

Typical and atypical phenotypes of PNPO deficiency with elevated CSF and plasma pyridoxamine on treatment.

Ware TL, Earl J, Salomons GS, Struys EA, Peters HL, Howell KB, Pitt JJ, Freeman JL.

Dev Med Child Neurol. 2014 May;56(5):498-502. doi: 10.1111/dmcn.12346. Epub 2013 Nov 23.

19.

Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells.

Peters HL, Yan Y, Nordgren TM, Cutucache CE, Joshi SS, Solheim JC.

Cancer Biol Ther. 2013 Aug;14(8):752-60. doi: 10.4161/cbt.25183. Epub 2013 Jun 26.

20.

Treatment of a methylmalonyl-CoA mutase stopcodon mutation.

Buck NE, Wood LR, Hamilton NJ, Bennett MJ, Peters HL.

Biochem Biophys Res Commun. 2012 Nov 2;427(4):753-7. doi: 10.1016/j.bbrc.2012.09.133. Epub 2012 Oct 4.

PMID:
23041189
21.

Development of transgenic mice containing an introduced stop codon on the human methylmalonyl-CoA mutase locus.

Buck NE, Dashnow H, Pitt JJ, Wood LR, Peters HL.

PLoS One. 2012;7(9):e44974. Epub 2012 Sep 14.

22.

Fetal progenitor cell transplantation treats methylmalonic aciduria in a mouse model.

Buck NE, Pennell SD, Wood LR, Pitt JJ, Allen KJ, Peters HL.

Biochem Biophys Res Commun. 2012 Oct 12;427(1):30-5. doi: 10.1016/j.bbrc.2012.08.134. Epub 2012 Sep 12.

PMID:
22982631
23.

Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells.

Peters HL, Tuli A, Wang X, Liu C, Pan Z, Ouellette MM, Hollingsworth MA, Macdonald RG, Solheim JC.

Int J Oncol. 2012 Oct;41(4):1464-74. doi: 10.3892/ijo.2012.1553. Epub 2012 Jul 13.

24.

Mouse models for methylmalonic aciduria.

Peters HL, Pitt JJ, Wood LR, Hamilton NJ, Sarsero JP, Buck NE.

PLoS One. 2012;7(7):e40609. doi: 10.1371/journal.pone.0040609. Epub 2012 Jul 9.

25.

Regulation of major histocompatibility complex class I molecule expression on cancer cells by amyloid precursor-like protein 2.

Peters HL, Tuli A, Sharma M, Naslavsky N, Caplan S, MacDonald RG, Solheim JC.

Immunol Res. 2011 Oct;51(1):39-44. doi: 10.1007/s12026-011-8238-6. Review.

26.

Prediction of nasal morphology from the skull.

Rynn C, Wilkinson CM, Peters HL.

Forensic Sci Med Pathol. 2010 Mar;6(1):20-34. doi: 10.1007/s12024-009-9124-6.

PMID:
19924578
27.

Stop codon read-through of a methylmalonic aciduria mutation.

Buck NE, Wood L, Hu R, Peters HL.

Mol Genet Metab. 2009 Aug;97(4):244-9. doi: 10.1016/j.ymgme.2009.04.004. Epub 2009 Apr 12.

PMID:
19427250
28.

Gene induction for the treatment of methylmalonic aciduria.

Hu R, Buck NE, Khaniani MS, Wood L, Wardan H, Benoist JF, Li L, Vadolas J, Sarsero JP, Ioannou PA, Peters HL.

J Gene Med. 2009 Apr;11(4):361-9. doi: 10.1002/jgm.1297.

PMID:
19199343
29.

Three-year audit of the hyperphenylalaninaemia/phenylketonuria spectrum in Victoria.

Boneh A, Francis DE, Humphrey M, Upton HJ, Peters HL.

J Paediatr Child Health. 2006 Sep;42(9):496-8.

PMID:
16925533
30.

POLG mutations and Alpers syndrome.

Davidzon G, Mancuso M, Ferraris S, Quinzii C, Hirano M, Peters HL, Kirby D, Thorburn DR, DiMauro S.

Ann Neurol. 2005 Jun;57(6):921-3.

PMID:
15929042
31.

Choice with initial and terminal link reinforcement: an alternative self-control paradigm.

Peters HL, Hunt M, Harper DN.

J Exp Psychol Anim Behav Process. 2004 Jan;30(1):74-7.

PMID:
14709117
32.

Determination of trace metals in drinking water using solid-phase extraction disks and X-ray fluorescence spectrometry.

Hou X, Peters HL, Yang Z, Wagner KA, Batchelor JD, Daniel MM, Jones BT.

Appl Spectrosc. 2003 Mar;57(3):338-42.

PMID:
14658627
33.
34.

Molecular studies in mutase-deficient (MUT) methylmalonic aciduria: identification of five novel mutations.

Peters HL, Nefedov M, Lee LW, Abdenur JE, Chamoles NA, Kahler SG, Ioannou PA.

Hum Mutat. 2002 Nov;20(5):406.

PMID:
12402345
35.
37.

Benzene exposure, assessed by urinary trans,trans-muconic acid, in urban children with elevated blood lead levels.

Weaver VM, Davoli CT, Heller PJ, Fitzwilliam A, Peters HL, Sunyer J, Murphy SE, Goldstein GW, Groopman JD.

Environ Health Perspect. 1996 Mar;104(3):318-23.

38.

Observations of the Glycolytic Power of the Blood and Tissues in Normal and Diabetic Conditions.

Milne LS, Peters HL.

J Med Res. 1912 Jul;26(3):415-39. No abstract available.

39.

Atrophy of the Pancreas after Occlusion of the pancreatic Duct.

Milne LS, Peters HL.

J Med Res. 1912 Jul;26(3):405-414.5. No abstract available.

Supplemental Content

Loading ...
Support Center